Trial averages are population-level statistics, not guarantees
They are made by different companies (Innovent Biologics and Eli Lilly, respectively), have different clinical trial programs, and produce different levels of weight loss
Additionally, semaglutide GLP-1 injections, when given under medical supervision, can also help to reduce appetite, leading to weight loss
Exenatide extended-release carries a boxed warning for thyroid C-cell tumors and is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
There is also the risk of losing muscle and decreased exercise output
Take a Quiz Our products leverage the power of compounded semaglutide and tripeptides to promote weight loss effectively